Predictors of Adherence to Anti-Hypertensive Therapy: Systematic Review and Meta-Analysis
Main Article Content
Abstract
Low adherence to antihypertensive therapy is one of the main modifiable risk factors for several other secondary pathologies. Therefore, we aimed to evaluate the predictors that most interfere in the adherence process. This is a systematic review with meta-analysis that followed the Cochrane recommendations, the search for studies occurred between January and February 2020 using the MeSH: "Hypertensive", "Medication Adherence", "World Population" and "Risk Factors". After applying the filters and criteria 31 studies were selected. The review included studies with intended perspectives and the main predictors were: interventions, satisfaction, cost reduction, the factors were also found: diagnostic impact, medical inertia and execution of the prescribed regimes. The research exposed that more work is needed on health promotion by age group and hypertension (SAH) can be detected and controlled early, readjust high costs, ensure well-being and satisfaction in therapy so that the patient can feel comfortable. Personalized recommendations and constructive comments can drive this process, it is necessary to develop actions aimed at greater compliance by reducing the impact of these diseases and promoting greater control Compliance has always been complex by nature. However, relatively small interventions can substantially improve it.
Keywords: Hypertensive; Medication Adherence; World Population; e Risk Factors.
Metrics
Article Details
This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
References
Aronow, Wilbert S. Optimal Blood Pressure Goals in Patients With Hypertension at High Risk for Cardiovascular Events. Am J Ther | MEDLINE ID: mdl-2359102423(1): e218-23, Jan-Feb. 2017.. [Acesso 3 de janeiro de 2020]. Disponível em: <10.1097/MJT.0b013e31827c5372.>.
Mariampillai, Julian E; Eskås, Per Anders; Heimark, Sondre; Larstorp, Anne Cecilie K; Fadl Elmula, Fadl Elmula M; Høieggen, Apparent treatment-resistant hypertension - patient-physician relationship and ethical issues. Aud; Nortvedt, Per. Jun. Artigo em Inglês | MEDLINE | ID: mdl-28078909. Blood Press; 26(3): 133-138, 2017.
Islam MS Hypertension: From Basic Research to Clinical Practice. Islam, Md Shahidul. Adv Exp Med Biol; 956: 1-2, 2017. Disponível em: <10.1007/5584_2017_30>
Madeleine M. Baker-Goering, PhD 1; Kakoli Roy, PhD 1; David H. Howard, PhD 2 Relação entre adesão ao regime de medicação anti-hipertensiva e custos diretos entre pessoas de 35 a 64 anos com seguro de saúde patrocinado pelo empregador. Prev Chronic Dis 2019.
Burnier, M. Drug adherence in hypertension. Pharmacol Res; 125(Pt B): 142-149, 2017 Nov.
Oluwole, Esther O; Osibogun, Olatokunbo; Adegoke, Oluseyi; Adejimi, Adebola A; Adewole, Ajoke M; Osibogun, Akin. Medication adherence and patient satisfaction among hypertensive patients attending outpatient clinic in Lagos University Teaching Hospital, Nigeria.
Niger Postgrad Med J; 26(2): 129-137, Apr-Jun. 2019.
Jager Sympathy trial. de, Rosa L; van Maarseveen, Erik M; Bots, Michiel L; Blankestijn, Peter J. Br J Clin Pharmacol; Medication adherence in patients with apparent resistant hypertension: findings from the 84(1): 18-24, Jan 2018.
Chaddha, Ashish; Erickson, Steven; Kline-Rogers, Eva; Montgomery, Daniel; Woznicki, Elise; Jabara, Justin; Eagle, KimMedication adherence patterns in aortic dissection survivors.. Indian J Med Res; 147(2): 183-188, Feb 2018.
Amer, Muhammad; Rahman, Nisarur; Nazir, Saeedur Rashid; Raza, Atif; Riaz, Humayun; Sultana, Misbah; Sadeeqa, Saleha. Impact of pharmacist's intervention on disease related knowledge, medication adherence, HRQoL and control of blood pressure among hypertensive patients Pak J Pharm Sci; 31(6 (Supplementary): 2607-2616, Nov 2018.
Adeoye, Abiodun Moshood; Adebiyi, Akindele Olupelumi; Adebayo, Oladimeji Muritala; Owolabi, Mayowa Ojo. Medication adherence and 24-h blood pressure in apparently uncontrolled hypertensive Nigerian patients. Niger Postgrad Med J; 26(1): 18-24, Jan-Mar. 2019.
Rachel Hennein, Shih‐Jen Hwang, Rhoda Au. Barreiras à medicação aderência e Links para Cardiovascular Disease Control Risk Factor: O Framingham Heart Study. Volume48, Issue4April 2018 Pages 414-421Internal Medicine Journal. 30 November 2017[acesso 3 de janeiro de 2020]. Disponível em: <https://doi.org/10.1111/imj.13687>.
Julia R Smith, Lisa Hillman &Paul E Drawz. Pharmacist-based antihypertensive medication review and assignment of morning versus evening dosing of once-daily antihypertensive medications: A pilot study to assess feasibility and efficacy in chronic kidney disease patients. Pages 569-573 | Published online: 06 Dec 2017. [Acesso 03/01/2020]. Disponível em: <https://www.tandfonline.com/doi/full/10.1080/10641963.2017.1411493>.
Morawski K,Roya G, Alexis Krumme MS,Julianne Mc DonoughBSErin Durfee BSbLeslieOley MSbNamita Mohta MDaJessie Juusola, Niteesh K.Choudhry. Rationale and design of the Medication adherence Improvement Support App For Engagement—Blood Pressure (MedISAFE-BP) trial American Heart Journal. Volume 186, April 2017, Pages 40-47. [Acesso 4 de janeiro de 2020]. Disponível em: https://doi.org/10.1016/j.ahj.2016.11.007.
Lauffenburger, J.C., Landon, J.E. & Fischer, M.A. J GEN INTERN MED (2017) 32: 619. https://doi.org/10.1007/s11606-016-3972-zEffect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study. J Gen Intern Med; 32(6): 619-625, 2017 Jun. [Acesso 4 de janeiro de 2020]. Disponível em: https://link.springer.com/article/10.1007%2Fs11606-016-3972-z.
Berhe DF, Taxis K, Haaijer-Ruskamp, Flora M. Impact of adverse drug events and treatment satisfaction on patient adherence with antihypertensive medication - a study in ambulatory patients. Volume83, Issue9, September 2017, Pages 2107-2117. Br J Clin Pharmacol; 83(9): 2107-2117, 2017 Sep. [Acesso 6 de janeiro de 2020]. Disponível em: https://doi.org/10.1111/bcp.13312.
Nashilongo, MM, Singu, B., Kalemeera, F. et al. Avaliação da adesão à terapia anti-hipertensiva na atenção primária à saúde na Namíbia: resultados e implicações. Cardiovascular Drugs and Therapy December 2017, Volume 31, Issue 5–6, pp 565–578 [Acesso 6 de janeiro de 2020]. Disponível em: 10.1007 / s10557-017-6756-8.
Choi, K.H., Yu, Y.M., Ah, Y. et al. Persistence with antihypertensives in uncomplicated treatment-naïve very elderly patients: a nationwide population-based study. BMC Cardiovasc Disord17, 232 (2017). 578 [Acesso 6 de janeiro de 2020]. Disponível em: https://doi.org/10.1186/s12872-017-0665-4.
Sung FS. Previously undiagnosed risk factors and medication nonadherence are prevalent in young adults with first‐ever stroke. Volume26, Issue12. December 2017. Pages 1458-1464. Disponível em: https://doi.org/10.1002/pds.4250.
Andrews AB. The impact of an appointment‐based medication synchronization programme on chronic medication adherence in an adult community pharmacy population. Volume42, Issue4. August 2017. Pages 461-466. Disponível em: https://doi.org/10.1111/jcpt.12533.
Nidal F. Eshah. (2018) Investigating cardiovascular patients’ preferences and expectations regarding the use of social media in health education. Contemporary Nurse 54:1, pages 52-63. Disponível em: https://doi.org/10.1080/10641963.2016.1247164.
Tang, K.L., Quan, H. & Rabi, D.M. Measuring medication adherence in patients with incident hypertension: a retrospective cohort study. BMC Health Serv Res17, 135 (2017). Disponível em:https://doi.org/10.1186/s12913-017-2073-y.
Bandi P. Age-Related Differences in Antihypertensive Medication Adherence in Hispanics: A Cross-Sectional Community-Based Survey in New York City, 2011–2012. ORIGINAL RESEARCH — Volume 14 — July 13, 2017. Disponível em: https://www.cdc.gov/pcd/issues/2017/16_0512.htm.
Park H., Adeyemi A., Wang W., Roane T.E. Impact of a telephonic outreach program on medication adherence in Medicare Advantage Prescription Drug (MAPD) plan beneficiaries. (2017) Journal of the American Pharmacists Association, 57 (1), pp. 62-66.e 2. Disponível em: https://doi.org/10.1016/j.japh.2016.07.006.
Son YJ. Depression and medication adherence among older Korean patients with hypertension: Mediating role of self‐efficacy. Volume 23, Issue3 June 2017 e12525. Disponível em:https://doi.org/10.1111/ijn.12525.
Jeong, H., Kim, H., Lee, K. et al. Medical visits, antihypertensive prescriptions and medication adherence among newly diagnosed hypertensive patients in Korea. Environ Health Prev Med22, 10 (2017). Disponível em: https://doi.org/10.1186/s12199-017-0619-6.
Abel W, Greer D. Spiritual/Religious Beliefs & Medication Adherence in Black Women with Hypertension. Journal of Christian Nursing. 34(3):164–169, /September 2017. Disponível em: JULY/SEPTEMBER 2017.DOI:10.1097/CNJ.0000000000000333.
Zhuo Yang, David H. Howard, Julie Will., Fleetwood Loustalot Associação da adesão aos medicamentos anti-hipertensivos com uso em cuidados de saúde e gastos com medicamentos para eventos cardiovasculares agudos. Volume 00, Número 00, '' 2016. Disponível em: 10.1097/MLR.0000000000000515.
Kronish, I.M., Moise, N., McGinn An Electronic Adherence Measurement Intervention to Reduce Clinical Inertia in the Treatment of Uncontrolled Hypertension: The MATCH Cluster Randomized Clinical Trial. Journal of General Internal Medicine. November 2016, Volume 31, Issue 11, pp 1294–1300. Disponível em: https://doi.org/10.1007/s11606-016-3757-4.
Garza KB, Owensby JK. Pilot Study to Test the Effectiveness of Different Financial Incentives to Improve Medication. Adherence. Anais de Farmacoterapia. Vol 50, Issue 1, 2016. Disponível em: https://doi.org/10.1177/1060028015609354.
Lo SH, Chau JP, Woo J, Thompson D, Choi K. Adherence to Antihypertensive Medication in Older Adults With Hypertension. Journal of Cardiovascular Nursing. Vol. 31, No. 4, pp 296Y303. August 2016. Disponível em: 10.1097/JCN.0000000000000251.
Shiremam T. I, Svarstad BL, Cost-effectiveness of Wisconsin TEAM model for improving adherence and hypertension control in black patients. Jurnal of the American Pharmacists Association Volume 56, Issue 4, Pages 389–396. August, 2016. Disponível em: https://doi.org/10.1016/j.japh.2016.03.002.
Higgins JPT, Verde S, editores. Handook Cochrane para revisões sistemáticas de intervenções: Versão 5.1.0 [atualizado março de 2011. Londres: Cochrane Formação; 2011 [citado 2014 06 de novembro]. Disponível em: http://handbook.cochrane.org/
Santos Cristina Mamédio da Costa, Pimenta Cibele Andrucioli de Mattos, Nobre Moacyr Roberto Cuce. The PICO strategy for the research question construction and evidence search/ A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências.Rev. Latino-Am. Enfermagem [Internet]. 2007 June [cited 2020 Feb 13]; 15(3): 508-511. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692007000300023&lng=en. http://dx.doi.org/10.1590/S0104-11692007000300023.
Galvão TF, Pansani TS, Harrad D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Epidemiol Serv Saude. 2015;24:335-42. http://dx.doi.org/10.5123/S1679-49742015000200017.
Villacorta, PJ.; Rabelo, CA.; Pelta, DA.; Verdegay, JL. Fuzzy LP: an R Package for Solving Fuzzy Linear Programming Problems. Departamento de Ciências da Computação e Inteligência Artificial. Espanha, Universidade de Granada. Disponível em: https://cran.r-project.org/web/packages/FuzzyLP/vignettes/FuzzyLP.pdf>.
Downs SH BN. The feasibility of creating a checklist forthe assessment of the methodological quality both of randomi-sed and non-randomised studies of health care interventions. J Epidemiol Community Heal. 1998.
V Diretrizes Brasileiras de Hipertensão Arterial. Arq. Bras. Cardiol. [Internet]. 2007 Sep [cited 2020 Feb 21] ; 89( 3 ): e24-e79. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066782X2007001500012&lng=en. https://doi.org/10.1590/S0066782X2007001500012.